AU:CGS Stock Latest News
Company AnnouncementsCogstate Director Receives $1.05 Million in Performance Rights20m ago
Company AnnouncementsCogstate Issues 355,866 Unquoted Performance Rights44m ago
Company AnnouncementsCogstate CEO Reshapes Equity Holdings After Option Exercise and Share Sale3d ago
Company AnnouncementsCogstate seeks ASX quotation for 500,000 new shares4d ago
Company AnnouncementsCogstate Director Darryl Inns Acquires First Stake with On-Market Share Purchase6d ago
Company AnnouncementsCogstate Shares AGM Address and Emphasises Caution on Forward-Looking Statements2w agoCompany AnnouncementsCogstate boosts long-term revenue with major wins in mood disorder trials3w ago
Company AnnouncementsCogstate Issues Over 1 Million Unquoted Performance Rights Under Employee Scheme3w ago
Company AnnouncementsCogstate Seeks ASX Quotation for Additional Ordinary Shares3w ago- Company AnnouncementsCogstate Sets Hybrid 2026 AGM to Decide Governance and Executive Pay1M ago
Company AnnouncementsCogstate Adjusts Incentive Pool as Performance Rights Lapse1M ago- Company AnnouncementsCogstate Lists Additional Shares on ASX Following Option Conversions2M ago
Company AnnouncementsCogstate lifts earnings on record trials and AI push2M ago
Company AnnouncementsCogstate posts record FY26 results and deepens AI-enabled CNS trial platform2M ago
- Company AnnouncementsCogstate lifts profit and doubles dividend as clinical trials revenue surges2M ago
- Company AnnouncementsCogstate Sets Board Nomination Deadline Ahead of 2026 AGM2M ago
- Company AnnouncementsCogstate Updates Market on Lapse of Options and Performance Rights3M ago
Company AnnouncementsCogstate Seeks ASX Quotation for Additional Ordinary Shares3M ago
Company AnnouncementsCogstate Posts Record FY26 Sales and Expands Contracted Revenue Pipeline3M agoCompany AnnouncementsCogstate targets sustainable growth via expanded clinical trial indications and services4M ago